Ignite Creation Date:
2025-12-24 @ 11:51 PM
Ignite Modification Date:
2026-01-10 @ 5:51 PM
Study NCT ID:
NCT05199051
Status:
RECRUITING
Last Update Posted:
2025-02-19
First Post:
2021-11-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2 Study of Gemtuzumab Ozogamicin (GO)-Gilteritinib Combination in Adults with FLT3-ITD Relapse/refractory (R/R) AML
Sponsor:
Organization: